You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ACH-0145228

Showing 1 - 25 of 89
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Adult Participants Trial in Baltimore (Treatment A, Treatment B, Treatment C)

Completed
  • Healthy Adult Participants
  • Treatment A
  • +2 more
  • Baltimore, Maryland
    Baltimore Parexel EPCU
Jan 19, 2023

Healthy Trial in Lincoln (ACH-0145228: Immediate Release, ACH-0145228: Powder-in-capsule)

Completed
  • Healthy
  • ACH-0145228: Immediate Release
  • ACH-0145228: Powder-in-capsule
  • Lincoln, Nebraska
    Clinical Trial Site
Dec 8, 2021

Healthy Trial in Auckland (ALXN2050, Placebo)

Completed
  • Healthy
  • Auckland, New Zealand
    Clinical Trial Site
Sep 9, 2021

Healthy Trial in Auckland (ALXN2050, Placebo)

Completed
  • Healthy
  • Auckland, New Zealand
    Clinical Trial Site
Sep 9, 2021

Healthy Trial in Lincoln ([14C]-ALXN2050)

Completed
  • Healthy
  • Lincoln, Nebraska
    Clinical Trial Site
Jan 23, 2023

Healthy Trial in Tempe (ALXN2050, Fluconazole, Rifampin)

Completed
  • Healthy
  • Tempe, Arizona
    Clinical Trial Site
Dec 7, 2022

Renal Impairment, Healthy Trial in Hialeah, Orlando (ALXN2050)

Completed
  • Renal Impairment
  • Healthy
  • Hialeah, Florida
  • +1 more
Oct 12, 2022

Impaired Hepatic Function, Healthy Trial in Hialeah, Orlando (ALXN2050)

Recruiting
  • Impaired Hepatic Function
  • Healthy
  • Hialeah, Florida
  • +1 more
May 11, 2022

Healthy Trial in Tempe (ACH-0145228, Midazolam, Digoxin)

Completed
  • Healthy
  • ACH-0145228
  • +3 more
  • Tempe, Arizona
    Clinical Study Site
Jan 12, 2021

Healthy Trial in Tempe (ALXN2050, Placebo)

Completed
  • Healthy
  • Tempe, Arizona
    Clinical Trial Site
Dec 9, 2021

Healthy Trial in Tempe (ALXN2050, ALXN2050-matching Placebo, Moxifloxacin)

Completed
  • Healthy
  • Tempe, Arizona
    Clinical Trial Site
Dec 9, 2021

Generalized Myasthenia Gravis, Myasthenia Gravis Trial in Worldwide (ALXN2050, Placebo)

Recruiting
  • Generalized Myasthenia Gravis
  • Myasthenia Gravis
  • Phoenix, Arizona
  • +45 more
Dec 15, 2022

Lupus Nephritis, Immunoglobulin A Nephropathy, IgAN Trial in United States (ALXN2050, Placebo)

Recruiting
  • Lupus Nephritis
  • +3 more
  • Huntsville, Alabama
  • +49 more
Jan 25, 2023

Angina Pectoris, Variant, Angina Pectoris; Spasm-Induced, Angina Pectoris With Normal Coronary Arteriogram Trial in Antwerp

Recruiting
  • Angina Pectoris, Variant
  • +2 more
  • Acetylcholine rechallenge
  • Antwerp, Belgium
    University Hospital Antwerp
Jan 17, 2023

Healthy Volunteers Trial in Melbourne (ACH-000029, Placebo)

Terminated
  • Healthy Volunteers
  • Melbourne, Victoria, Australia
    Nucleus Network Pty Ltd
Jan 30, 2023

Smoking, Schizophrenia Trial in New Haven (Physostigmine)

Completed
  • Smoking
  • Schizophrenia
  • New Haven, Connecticut
  • +2 more
Oct 24, 2022

Children With Achondroplasia (ACH)

Recruiting
  • Achondroplasia
    • Oakland, California
    • +19 more
    Apr 6, 2022

    Achondroplasia Trial (Navepegritide, Placebo for Navepegritide)

    Not yet recruiting
    • Achondroplasia
    • (no location specified)
    Oct 6, 2023

    HCV Infection Trial in Germany, Netherlands, United States (ACH-0137171)

    Terminated
    • HCV Infection
    • Phoenix, Arizona
    • +8 more
    Sep 14, 2022

    Diabetes Trial in Jacksonville (Continuous Glucose Monitor Dexcom G6 PRO)

    Not yet recruiting
    • Diabetes Mellitus
    • Continuous Glucose Monitor Dexcom G6 PRO
    • Jacksonville, Florida
      Mayo Clinic in Florida
    May 16, 2023

    C3 Glomerulopathy, C3 Glomerulonephritis, Dense Deposit Disease Trial in United Kingdom, United States (Danicopan, Placebo)

    Completed
    Has Results
    • C3 Glomerulopathy
    • +2 more
    • Aurora, Colorado
    • +6 more
    Oct 7, 2022

    Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (Danicopan)

    Completed
    Has Results
    • Paroxysmal Nocturnal Hemoglobinuria (PNH)
    • Florence, Italy
    • +4 more
    May 31, 2022

    C3 Glomerulonephritis, C3 Glomerulopathy, Immune Complex Membranoproliferative Glomerulonephritis Trial in Worldwide (Danicopan)

    Terminated
    Has Results
    • C3 Glomerulonephritis
    • +4 more
    • Birmingham, Alabama
    • +12 more
    Aug 9, 2022

    Adaption and Testing of Quality of Life in Short Stature Youth

    Recruiting
    • Achondroplasia
    • +2 more
    • Questionnaire
    • Hamburg, Germany
      University Medical Center Hamburg-Eppendorf
    Oct 28, 2022

    Achondroplasia Trial in Worldwide (Infigratinib 0.016 mg/kg, Infigratinib 0.032 mg/kg, Infigratinib 0.064 mg/kg)

    Recruiting
    • Achondroplasia
    • Infigratinib 0.016 mg/kg
    • +3 more
    • Oakland, California
    • +17 more
    Apr 5, 2022